Creative Bioarray Built Professional Cell Reprogramming Services with Cutting-edge Technologies to Accelerate Drug Development and Research

January 24 12:57 2022
Creative Bioarray announced the release of its professional cell reprogramming services with cutting-edge technologies to accelerate drug development and research.

New York, USA – January 24, 2022 – Cell culture platform, the division of Creative Bioarray, focuses on developing complete cell culture solutions with plenty of choices for the next breakthrough in cell culture applications. With customized products and comprehensive cell-based services, Creative Bioarray is dedicated to accelerating scientific research and drug development. Recently, Creative Bioarray announced the release of its professional cell reprogramming services with cutting-edge technologies to accelerate drug development and research.

Cell reprogramming offers multiple opportunities in clinical applications ranging from wound healing to the treatment of complex diseases. Cell reprogramming holds great potential for new medical applications such as cell replacement therapy and tissue engineering. In the future, iPSCs may provide an infinite number of replacement cells and tissues for patients with currently incurable diseases.

Creative Bioarray can provide different cell reprogramming methods for different cell types and purposes. The reprogrammed cells will be fully identified and well cryopreserved. Genetic cell reprogramming techniques offered by Creative Bioarray have identified multiple transcription factors capable of reprogramming somatic cells into pluripotent cells. Rapid advances in genetic manipulation technologies, such as viral vectors, episomal plasmid vectors, piggyBac transposons, mRNA- and miRNA-based reprogramming, protein-based approaches, and CRISPR technologies, can be used to deliver specific cocktails of reprogramming factors or to facilitate genome editing.

As a useful cell reprogramming technique, cell fusion-induced reprogramming is an effective method and an important tool to study the mechanism of reprogramming. By fusing with pluripotent cells, somatic cells can be reprogrammed to a pluripotent state. Among them, chemical modification, virus mediation and electric shock are commonly used methods.

Chemical reprogramming can reprogram one somatic cell type into another desired cell type, such as glial cells, neuronal cells, and cardiomyocytes. This virus-free, oncogene-free approach, with little impact on genome integrity and cellular function, is ideal for further reducing the risk of tumorigenesis.

“Creative Bioarray can provide custom cell reprogramming services with fast turnaround time and competitive price. We can also conduct follow-up experiments at your request,” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “Specialized media for cell reprogramming can also be customized at our platform.”

About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States